Skip to main content
Search
Audio Interview

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Published on June 2, 2021   12 min

Other Talks in the Playlist: Interviews on Covid-19

Please wait while the transcript is being prepared...
0:00
Interviewer: Professor Sabine Eichinger, thank you very much for taking the time to do this interview with us today to discuss the phenomenon by which COVID-19 vaccines have produced a few reports of severe blood clotting adverse reactions so far. First and foremost, are clotting complications known adverse events of vaccines in general, are these reported cases something completely new, or are these specifically related to the new COVID vaccines (i.e. to the new technology of nucleic acid vaccines)? Prof. Eichinger: Thank you very much for the invitation. So far we have only observed these clotting side-effects with two COVID-19 vaccines, the AstraZeneca vaccine and the Johnson & Johnson Janssen vaccine. There are no reports on other vaccines about these kinds of blood-clotting side-effects which we have observed with these two vector vaccinations. Interviewer: Can you provide a bit more context as to these vaccine-related adverse events? How often do they happen in relation to the total number of inoculations? Prof. Eichinger: These are definitely very rare events. The exact number is still unknown particularly also because of the different vaccination programs between countries. There are countries who haven't used, let's say, the AstraZeneca vaccine that frequently (compared to other countries), and then

Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.

If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)

Show
Hide

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Embed in course/own notes